Dr. Agarwal's Health Care Ltd. (AGARWALEYE) Price & Analysis

Compare

0 Followers

AGARWALEYE Stock Chart & Stats

₹500.00

Market closed

₹500.00

Day’s Range― - ―

52-Week Range₹327.40 - ₹567.80

Previous CloseN/A

VolumeN/A

Average Volume (3M)13.83K

Market Cap

₹142.20B

Enterprise Value₹150.28B

Total Cash (Recent Filing)₹5.13B

Total Debt (Recent Filing)₹0.00

Price to Earnings (P/E)118.8

Beta0.54

Next Earnings

Jun 03, 2026

EPS Estimate

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)1.10

Shares Outstanding316,807,500

10 Day Avg. Volume7,500

30 Day Avg. Volume13,832

Financial Highlights & Ratios

PEG Ratio43.43

Price to Book (P/B)7.19

Price to Sales (P/S)7.85

P/FCF Ratio589.13

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)4.02

Revenue Forecast (FY)₹20.63B

Bulls Say, Bears Say

Bulls Say

Comprehensive Eye-care NetworkThe company's integrated network of ophthalmology hospitals, clinics, diagnostics, surgery and optical/pharmacy services creates diversified, recurring revenue streams. This model supports cross-selling, patient retention and operating leverage, underpinning steady demand and scalable growth over months.

Consistent Strong Cash GenerationConsistent positive operating cash flow and growing free cash flow indicate robust cash generation that funds operations and expansion. Strong operating cash relative to net income enhances financial resilience, enabling capital expenditure, deleveraging or reinvestment without relying solely on external financing.

Improving Margins And ProfitabilityHealthy gross margins and rising EBIT/EBITDA margins reflect better cost management and operational efficiency. Improved margins enhance long-term cash conversion and the ability to absorb incremental SG&A or financing costs, supporting sustainable profit growth as the business scales its network.

Bears Say

Moderate LeverageA moderately high debt-to-equity ratio indicates notable reliance on debt funding. Persistent leverage raises interest burden and reduces financial flexibility, making the company more sensitive to cash flow swings or higher funding costs and requiring disciplined cash generation to service obligations over time.

Volatile Net Profit MarginsReported net profit margin volatility suggests earnings are affected by variable expenses or financing costs. Margin swings reduce predictability of free cash flow and make capital allocation decisions harder, potentially constraining consistent reinvestment, dividend capacity or buffer during industry slowdowns.

Opaque Expansion MetricsGrowth is described as driven by network expansion but center counts and same-store data are not disclosed. This opacity hinders assessment of organic growth, new-center ROI and scalability. Execution risk rises if expansion economics or unit-level performance are unclear to investors.

Dr. Agarwal's Health Care Ltd. News

Dr. Agarwal’s Health Care Grants 4.44 Lakh ESOPs Under 2022 Scheme

The latest announcement is out from Dr. Agarwal’s Health Care Ltd. ( ($IN:AGARWALEYE) ). Dr. Agarwal’s Health Care...

1M ago

Dr. Agarwal’s Health Care Gets Clean Monitoring Report on IPO Proceeds Utilisation

Dr. Agarwal’s Health Care Ltd. ( ($IN:AGARWALEYE) ) has issued an announcement. Dr. Agarwal’s Health Care Limited has...

1M ago

Dr. Agarwal’s Health Care Sets Board Meet and Analyst Call for Q3 FY26 Results

Dr. Agarwal’s Health Care Ltd. ( ($IN:AGARWALEYE) ) has shared an update. Dr. Agarwal’s Health Care Limited has...

1M ago

Dr. Agarwal’s Health Care Announces Equity Share Allotment to Employees

Dr. Agarwal’s Health Care Ltd. ( ($IN:AGARWALEYE) ) has issued an update. Dr. Agarwal’s Health Care Limited has...

3M ago

Dr. Agarwal’s Health Care Ltd. Expands Employee Stock Options

Dr. Agarwal’s Health Care Ltd. ( ($IN:AGARWALEYE) ) just unveiled an update. Dr. Agarwal’s Health Care Ltd. announced...

4M ago

Dr. Agarwal’s Health Care Ltd. Confirms Proper Utilization of IPO Proceeds

The latest update is out from Dr. Agarwal’s Health Care Ltd. ( ($IN:AGARWALEYE) ). Dr. Agarwal’s Health Care...

4M ago

Dr. Agarwal’s Health Care Expands Stake in Eye Hospital Subsidiary

Dr. Agarwal’s Health Care Ltd. ( ($IN:AGARWALEYE) ) has provided an announcement. Dr. Agarwal’s Health Care Ltd. has...

6M ago

Dr. Agarwal’s Health Care and Eye Hospital Announce Strategic Merger

Dr. Agarwal’s Health Care Ltd. ( ($IN:AGARWALEYE) ) has shared an announcement. Dr. Agarwal’s Health Care Limited and...

7M ago

Dr. Agarwal’s Health Care Announces Analyst Call on Proposed Merger

Dr. Agarwal’s Health Care Ltd. ( ($IN:AGARWALEYE) ) has provided an update. Dr. Agarwal’s Health Care Limited has...

7M ago

Dr. Agarwal’s Health Care Ltd. Announces Strategic Merger

Dr. Agarwal’s Health Care Ltd. ( ($IN:AGARWALEYE) ) has issued an announcement. Dr. Agarwal’s Health Care Ltd. has...

7M ago

AGARWALEYE FAQ

What was Dr. Agarwal's Health Care Ltd.’s price range in the past 12 months?

Dr. Agarwal's Health Care Ltd. lowest stock price was ₹327.40 and its highest was ₹567.80 in the past 12 months.

What is Dr. Agarwal's Health Care Ltd.’s market cap?

Dr. Agarwal's Health Care Ltd.’s market cap is ₹142.20B.

When is Dr. Agarwal's Health Care Ltd.’s upcoming earnings report date?

Dr. Agarwal's Health Care Ltd.’s upcoming earnings report date is Jun 03, 2026 which is in 84 days.

How were Dr. Agarwal's Health Care Ltd.’s earnings last quarter?

Dr. Agarwal's Health Care Ltd. released its earnings results on Feb 13, 2026. The company reported ₹1.1 earnings per share for the quarter, beating the consensus estimate of ₹1 by ₹0.1.

Is Dr. Agarwal's Health Care Ltd. overvalued?

According to Wall Street analysts Dr. Agarwal's Health Care Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Dr. Agarwal's Health Care Ltd. pay dividends?

Dr. Agarwal's Health Care Ltd. does not currently pay dividends.

What is Dr. Agarwal's Health Care Ltd.’s EPS estimate?

Dr. Agarwal's Health Care Ltd.’s EPS estimate is 1.

How many shares outstanding does Dr. Agarwal's Health Care Ltd. have?

Dr. Agarwal's Health Care Ltd. has 316,807,500 shares outstanding.

What happened to Dr. Agarwal's Health Care Ltd.’s price movement after its last earnings report?

Dr. Agarwal's Health Care Ltd. reported an EPS of ₹1.1 in its last earnings report, beating expectations of ₹1. Following the earnings report the stock price went down -0.84%.

Which hedge fund is a major shareholder of Dr. Agarwal's Health Care Ltd.?

Currently, no hedge funds are holding shares in IN:AGARWALEYE

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Dr. Agarwal's Health Care Ltd.

Dr. Agarwal's Health Care Limited operates eye hospitals in India and internationally. It offers cataract surgeries, such as small incision cataract surgery, phacoemulsification, robotic cataract surgery, and glued intraocular lens treatments; and refractive surgeries, including surgical procedures to correct the refractive error of the eye to get rid of or reduce dependence on glasses and contact lens. The company also provides surgical retinal treatments, corneal transplantation and pinhole pupilloplasty, oculoplasty, and surgeries for the treatment of glaucoma and pterygium; doctor consultation services; and diagnostic services for eye disorders along with non-surgical treatments, including retinal laser therapy and dry eye treatment services. It also sells glasses, lenses, contact lenses, and frames; and eye care-related pharmaceutical products. The company was incorporated in 2010 and is based in Chennai, India.